Nov 17, 2025
Microscopic Colitis: Understanding Chronic Diarrhea and Budesonide Treatment
Biosimilars offer major cost savings over brand-name biologics, but insurance barriers like prior authorization and same-tier placement make them hard to access. Patients pay nearly the same out-of-pocket costs - defeating the purpose.